Spyre Therapeutics Inc (NAS:SYRE)
$ 94.12 -8.05 (-7.88%) Market Cap: 8.17 Bil Enterprise Value: 7.59 Bil PE Ratio: 0 PB Ratio: 14.41 GF Score: 26/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1